Anja Apel

2.8k total citations
17 papers, 1.3k citations indexed

About

Anja Apel is a scholar working on Neurology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anja Apel has authored 17 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Neurology, 6 papers in Physiology and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anja Apel's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (4 papers) and Nuclear Receptors and Signaling (4 papers). Anja Apel is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Alzheimer's disease research and treatments (4 papers) and Nuclear Receptors and Signaling (4 papers). Anja Apel collaborates with scholars based in Germany, United States and Switzerland. Anja Apel's co-authors include Ingrid Herr, Heinz Schwarz, H. Peter Rodemann, Andreas Mayer, Hanswalter Zentgraf, Markus W. Büchler, Walter Maetzler, Stephan A. Kaeser, Mathias Jucker and Andrea Pilotto and has published in prestigious journals such as Neuron, PLoS ONE and Neurology.

In The Last Decade

Anja Apel

15 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anja Apel Germany	12	569	487	223	196	177	17	1.3k
Christoph G. Goemans United Kingdom	10	530 0.9×	412 0.8×	122 0.5×	178 0.9×	105 0.6×	10	1.5k
Ludger Hauck Canada	17	891 1.6×	235 0.5×	100 0.4×	122 0.6×	130 0.7×	24	1.3k
Chuyi Huang China	20	586 1.0×	204 0.4×	191 0.9×	74 0.4×	124 0.7×	50	1.2k
Zhiyuan Zhu China	19	554 1.0×	194 0.4×	171 0.8×	161 0.8×	340 1.9×	46	1.2k
Wei‐Bing Xie China	20	509 0.9×	170 0.3×	121 0.5×	110 0.6×	134 0.8×	41	1.0k
Ewa Matyja Poland	24	614 1.1×	308 0.6×	414 1.9×	187 1.0×	271 1.5×	127	1.9k
Chunyu Wang China	22	599 1.1×	118 0.2×	253 1.1×	143 0.7×	131 0.7×	71	1.3k
Arantxa Ortega‐Aznar Spain	19	676 1.2×	447 0.9×	416 1.9×	229 1.2×	304 1.7×	27	1.7k
Irina Mikolaenko United States	12	786 1.4×	118 0.2×	199 0.9×	127 0.6×	252 1.4×	27	1.4k
Sophia Havaki Greece	15	564 1.0×	143 0.3×	69 0.3×	179 0.9×	108 0.6×	41	1.1k

Countries citing papers authored by Anja Apel

Since Specialization

Citations

This map shows the geographic impact of Anja Apel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Apel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Apel more than expected).

Fields of papers citing papers by Anja Apel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Apel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Apel. The network helps show where Anja Apel may publish in the future.

Co-authorship network of co-authors of Anja Apel

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Apel. A scholar is included among the top collaborators of Anja Apel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Apel. Anja Apel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Apel, Anja, Karin Weber, Roland Schweizer, et al.. (2022). GH Responsiveness Is not Correlated to IGF1 P2 Promoter Methylation in Children With Turner Syndrome, GHD and SGA Short Stature. Frontiers in Endocrinology. 13. 897897–897897. 1 indexed citations

Kaeser, Stephan A., Benoit Lehallier, Mikael Thinggaard, et al.. (2021). A neuronal blood marker is associated with mortality in old age. Nature Aging. 1(2). 218–225. 33 indexed citations

Kaeser, Stephan A., Benoit Lehallier, Lisa M. Häsler, et al.. (2021). A neuronal blood marker is associated with mortality in old age. Zenodo (CERN European Organization for Nuclear Research).

Yılmaz, Rezzak, Antonio P. Strafella, Alice Bernard, et al.. (2018). Serum Inflammatory Profile for the Discrimination of Clinical Subtypes in Parkinson's Disease. Frontiers in Neurology. 9. 1123–1123. 15 indexed citations

Preische, Oliver, Stephanie A. Schultz, Anja Apel, et al.. (2018). P3‐251: SERUM NEUROFILAMENT LIGHT CHAIN LEVELS ARE ASSOCIATED WITH CSF NEUROFILAMENT LIGHT CHAIN, COGNITIVE STATUS, AND DISEASE PROGRESSION IN AUTOSOMAL DOMINANT AD. Alzheimer s & Dementia. 14(7S_Part_22).

Brockmann, Kathrin, Stefanie Lerche, Anja Apel, et al.. (2017). SNPs in Aβ clearance proteins. Neurology. 89(23). 2335–2340. 10 indexed citations

Maetzler, Walter, Valérie Hanssens, Alice Bernard, et al.. (2016). GDF15/MIC1 and MMP9 Cerebrospinal Fluid Levels in Parkinson’s Disease and Lewy Body Dementia. PLoS ONE. 11(3). e0149349–e0149349. 33 indexed citations

Bernhard, Felix, Sebastian Heinzel, Gerhard Binder, et al.. (2016). Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors. PLoS ONE. 11(3). e0150552–e0150552. 35 indexed citations

Bacioglu, Mehtap, Luı́s F. Maia, Oliver Preische, et al.. (2016). Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases. Neuron. 91(1). 56–66. 295 indexed citations

10.

Maetzler, Walter, Anja Apel, Markus Langkamp, et al.. (2014). Comparable Autoantibody Serum Levels against Amyloid- and Inflammation-Associated Proteins in Parkinson’s Disease Patients and Controls. PLoS ONE. 9(2). e88604–e88604. 34 indexed citations

11.

Maetzler, Walter, Andrea Pilotto, Anja Apel, et al.. (2014). In vivo markers of Parkinson’s disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody. Acta Neuropathologica. 128(6). 893–5. 7 indexed citations

12.

Rausch, Vanessa, Li Liu, Anja Apel, et al.. (2012). Autophagy mediates survival of pancreatic tumour‐initiating cells in a hypoxic microenvironment. The Journal of Pathology. 227(3). 325–335. 112 indexed citations

13.

Maetzler, Walter, You‐Yong Tian, Benjamin Schmid, et al.. (2012). Serum and Cerebrospinal Fluid Levels of Transthyretin in Lewy Body Disorders with and without Dementia. PLoS ONE. 7(10). e48042–e48042. 27 indexed citations

14.

Salnikov, Alexei V., Anja Apel, Georgios Kallifatidis, et al.. (2009). Targeting of cancer stem cell marker EpCAM by bispecific antibody EpCAMxCD3 inhibits pancreatic carcinoma. Journal of Cellular and Molecular Medicine. 13(9b). 4023–4033. 37 indexed citations

15.

Apel, Anja, Hanswalter Zentgraf, Markus W. Büchler, & Ingrid Herr. (2009). Autophagy—A double‐edged sword in oncology. International Journal of Cancer. 125(5). 991–995. 131 indexed citations

16.

Apel, Anja, Ingrid Herr, Heinz Schwarz, H. Peter Rodemann, & Andreas Mayer. (2008). Blocked Autophagy Sensitizes Resistant Carcinoma Cells to Radiation Therapy. Cancer Research. 68(5). 1485–1494. 442 indexed citations

17.

Apel, Anja, et al.. (2008). Suitability of human mesenchymal stem cells for gene therapy depends on the expansion medium. Experimental Cell Research. 315(3). 498–507. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact